Research / RIVN / Fundamental state Inspectable configuration
State dimensions Filing 0001874178-23-000058 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
203.44% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
14.21% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-65.59% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
149.44% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
189.23% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
-35.68% · CORE · VALID
Operating margin 100th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
-107.70% · CORE · VALID
R&D intensity 0th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
39.57% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
18.10% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/4 normalized Level 3 Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/9 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 4/9 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 242.46%
Current 203.44%
Delta -39.02% Capex Intensity Decreased
Previous 22.75%
Current 14.21%
Delta -8.54% Cash Generation Increased
Previous -121.41%
Current -65.59%
Delta 55.81% Growth Decreased
Previous 207.97%
Current 149.44%
Delta -58.53% Inventory Pressure Decreased
Previous 192.77%
Current 189.23%
Delta -3.54% Margin Increased
Previous -36.75%
Current -35.68%
Delta 1.08% Profitability Increased
Previous -114.63%
Current -107.70%
Delta 6.93% R And D Intensity Decreased
Previous 39.61%
Current 39.57%
Delta -0.04% Sbc Intensity Increased
Previous 16.15%
Current 18.10%
Delta 1.95% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.